EU seals deal with Pfizer for as many as 1.8 billion vaccine doses

EU seals deal with Pfizer for as many as 1.8 billion vaccine doses
Share This :

European Commission approved on a new Covid vaccine contract with Pfizer Inc. and BioNTech SE, paving the way for as many as 1.8 billion doses for 2021-2023, President Ursula von der Leyen said Saturday.

The contract is for a guaranteed 900 million shots, with an option for a further 900 million.

The new agreement includes clauses to allow the donation and reselling of doses, according to a diplomatic memo seen by Bloomberg. It also foresees monthly delivery schedules and sanctions for potential delays.

The commission is also in talks with Moderna Inc., Novavax Inc. and Valneva SE for additional shots. Meanwhile, deliveries of the Johnson & Johnson vaccine remain sparse as investigations continue into contaminated batches at a US plant.

Still, von der Leyen said last week that she expects enough doses of all vaccines to inocul ate the bulk of the bloc’s population to be available by July.

Saturday’s contract announcement comes after the commission chief said she’s open to discussing President Joe Biden’s proposal to waive patents on Covid-19 vaccines.

Von der Leyen said at a conference of European Union leaders on Friday that vaccine manufacturers in the bloc have exported about half of the shots they’ve produced, some 200 million in total, and urged the U.S. to match that effort.

, EU seals deal with Pfizer for as many as 1.8 billion vaccine doses, Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Source link

Share This :